Experienced in Thrombocytopenia

Nobuaki Matsubara

Chiba, JP 
Experienced in Thrombocytopenia
Chiba, JP 
OverviewLocationsClinical Research

Overview

Nobuaki Matsubara practices in Chiba, Japan. Matsubara is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. Their top areas of expertise are Prostate Cancer, Urothelial Cancer, Breast Cancer, Kidney Transplant, and Nephrectomy.

Their clinical research consists of co-authoring 171 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Thrombocytopenia.

Locations

Chiba, Japan
Other Locations
Kashiwa, Japan
Japan
Kashiwanoha, 2778577, Japan
Kobe, 6578501, Japan
Tokyo, Japan
Honkomagome, 1130025, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

171 Total Publications

A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer.
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Matsubara's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile